social.outsourcedmath.com

FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)


The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its own. It was approved in 2019 to treat severe depression.

#news #npr #publicradio #usa
posted by pod_feeder_v2
Susan ✶✶✶✶ reshared this.

This website uses cookies to recognize revisiting and logged in users. You accept the usage of these cookies by continue browsing this website.